Log In
BCIQ
Print this Print this
 

ACTX02

  Manage Alerts
Collapse Summary General Information
Company Avrygen Corp.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentDiscovery
Standard IndicationBreast cancer
Indication DetailsTreat triple negative breast cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today